|
|
![]() | ![]() | ![]() | ![]() |
This excerpt taken from the BP 6-K filed Nov 17, 2005. Research and development costs
Research costs are expensed as incurred.
Development costs are capitalized as intangible assets when a project has obtained internal sanction and the future recoverability of such costs can reasonably be regarded as assured. Such intangible assets are reviewed for impairment at each balance sheet date before being brought into use and once brought into use are amortized on a straight-line basis over the period of the expected benefit. The asset is carried at cost less any accumulated amortization and accumulated impairment losses.
This excerpt taken from the BP 6-K filed Sep 7, 2005. Research and development costs
Research costs are expensed as incurred.
Development costs are capitalized as intangible assets when a project has obtained internal sanction and the future recoverability of such costs can reasonably be regarded as assured. Such intangible assets are reviewed for impairment at each balance sheet date before being brought into use and once brought into use are amortized on a straight-line basis over the period of the expected benefit. The asset is carried at cost less any accumulated amortization and accumulated impairment losses.
This excerpt taken from the BP 6-K filed Sep 7, 2005. Research and development costs
Research costs are expensed as incurred.
Development costs are capitalized as intangible assets when a project has obtained internal sanction and the future recoverability of such costs can reasonably be regarded as assured. Such intangible assets are reviewed for impairment at each balance sheet date before being brought into use and once brought into use are amortized on a straight-line basis over the period of the expected benefit. The asset is carried at cost less any accumulated amortization and accumulated impairment losses.
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for BP: |
| |||||||